Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

This study has been terminated.

Study NCT00038805 Information provided by M.D. Anderson Cancer Center

First Received: June 5, 2002 Last Updated: June 23, 2005 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Mylotarg

Additional drug interventions recognized in this trial

Gemtuzumab

More general drug interventions related to this trial

Sponsors listed in this trial